LITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including mild to severe obstructive sleep apnea (OSA)), is excited to announce "Empowering Women to Champion Airway", a pioneering event that will transcend international boundaries and unite prominent women in the medical and dental fields to shed light on the pivotal role of airway health in human well-being.
The "Empowering Women to Champion Airway" conference will be held at the Vivos Institute in Denver, CO on February 1 and 2, 2024. This unprecedented assembly aims to forge stronger bonds between medical and dental professionals, with a specific emphasis on empowering women to spearhead positive transformations in the healthcare landscape through a focus on airway health.
Vivos was granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) on November 28, 2023 for treating severe OSA in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances. Vivos' CARE appliances include the flagship DNA oral appliance, the mRNA oral appliance and the mmRNA oral appliance. This represents the first time the FDA has ever granted an oral appliance a clearance to treat moderate and severe OSA in adults, 18 years of age and older along with positive airway pressure (PAP) and/or myofunctional therapy, as needed.
Dr. Manisha Witmans, a Board-Certified Sleep Specialist licensed in both the United States and Canada, expressed, "I'm grateful to be speaking at the Empowering Women to Champion Airway event which is a tremendous opportunity to enhance collaboration between medical and dental professionals regarding treatment of patients with OSA. The recent FDA 510(k) clearance for Vivos' CARE devices to address severe OSA is encouraging for both patients and clinicians as this gives medical professionals a new and potentially more desirable option to offer to their patients. Severe OSA is a prevalent and often underdiagnosed condition ...